ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.18
0.00%
US Tech 100
19,210.00
1.05%
S&P 500
5,505.00
0.00%
US Dollar vs CAD
1.37525
0.32%
Bitcoin
67,738.62
-0.61%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SeaStar Medical Holding Corporation (ICU)

  7. SeaStar Medical Holding Corporation (ICU) News

ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ICU
DateTimeSourceHeadlineSymbolCompany
07/17/20248:00AMGlobeNewswire Inc.Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’sNASDAQ:ICUSeaStar Medical Holding Corporation
07/16/20247:30AMGlobeNewswire Inc.CMS Grants Category B Coverage for Adults with Acute Kidney Injury Enrolled in SeaStar Medical’s Selective Cytopheretic Device Pivotal TrialNASDAQ:ICUSeaStar Medical Holding Corporation
07/12/20244:05PMPR Newswire (US)ICU SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class ActionNASDAQ:ICUSeaStar Medical Holding Corporation
07/12/20247:30AMGlobeNewswire Inc.SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution PartnerNASDAQ:ICUSeaStar Medical Holding Corporation
07/11/20243:05PMGlobeNewswire Inc.SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:ICUSeaStar Medical Holding Corporation
07/10/20248:00AMGlobeNewswire Inc.SeaStar Medical Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:ICUSeaStar Medical Holding Corporation
07/03/20247:30AMGlobeNewswire Inc.SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
06/11/20247:30AMGlobeNewswire Inc.SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care NephrologyNASDAQ:ICUSeaStar Medical Holding Corporation
06/10/20247:30AMGlobeNewswire Inc.SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage CompanyNASDAQ:ICUSeaStar Medical Holding Corporation
06/07/20247:30AMGlobeNewswire Inc.Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive InflammationNASDAQ:ICUSeaStar Medical Holding Corporation
06/06/20247:30AMGlobeNewswire Inc.SeaStar Medical Announces 25-for-1 Reverse Stock SplitNASDAQ:ICUSeaStar Medical Holding Corporation
05/22/20247:30AMGlobeNewswire Inc.Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant EligibilityNASDAQ:ICUSeaStar Medical Holding Corporation
05/14/20243:05PMGlobeNewswire Inc.SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
04/30/20247:30AMGlobeNewswire Inc.SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
04/17/20243:00PMGlobeNewswire Inc.SeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
04/11/20247:30AMGlobeNewswire Inc.SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceNASDAQ:ICUSeaStar Medical Holding Corporation
03/27/20247:30AMGlobeNewswire Inc.SeaStar Medical to Restate Financials, Sets Business Update Call for April 17NASDAQ:ICUSeaStar Medical Holding Corporation
03/12/20247:30AMGlobeNewswire Inc.SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsNASDAQ:ICUSeaStar Medical Holding Corporation
03/11/20243:05PMGlobeNewswire Inc.SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024NASDAQ:ICUSeaStar Medical Holding Corporation
02/27/20247:30AMGlobeNewswire Inc.Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureNASDAQ:ICUSeaStar Medical Holding Corporation
02/22/20246:58AMGlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:ICUSeaStar Medical Holding Corporation
02/22/20246:53AMGlobeNewswire Inc.FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
02/01/20247:30AMGlobeNewswire Inc.SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyNASDAQ:ICUSeaStar Medical Holding Corporation
01/26/20247:05AMGlobeNewswire Inc.SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketNASDAQ:ICUSeaStar Medical Holding Corporation
01/11/20243:05PMGlobeNewswire Inc.SeaStar Medical Appoints David A. Green as Chief Financial OfficerNASDAQ:ICUSeaStar Medical Holding Corporation
01/09/20247:30AMGlobeNewswire Inc.SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical IndicationsNASDAQ:ICUSeaStar Medical Holding Corporation
12/28/20237:30AMGlobeNewswire Inc.SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney InjuryNASDAQ:ICUSeaStar Medical Holding Corporation
12/13/20237:30AMGlobeNewswire Inc.SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical ExpertsNASDAQ:ICUSeaStar Medical Holding Corporation
11/14/20233:04PMGlobeNewswire Inc.SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNASDAQ:ICUSeaStar Medical Holding Corporation
10/31/20237:00AMGlobeNewswire Inc.Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic DeviceNASDAQ:ICUSeaStar Medical Holding Corporation
 Showing the most relevant articles for your search:NASDAQ:ICU

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
HIRU
Hiru (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
USOTC
AABB
Asia Broadband (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
BLEG
Branded Legacy (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
MAXN
Maxeon Solar Technologies
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved